<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Treatment options for older patients with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and for patients with relapsed/refractory <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> are limited, and outcomes are poor </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="50131">Decitabine</z:chebi>, a hypomethylating agent, is active in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, but its optimal dose and schedule are unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We report the efficacy and safety of repeated 10-day cycles of <z:chebi fb="0" ids="50131">decitabine</z:chebi> 20 mg/m(2) administered intravenously over 1 h in 52 newly diagnosed and 102 relapsed/refractory patients </plain></SENT>
<SENT sid="3" pm="."><plain>Repeated 10-day cycles of <z:chebi fb="0" ids="50131">decitabine</z:chebi> produced a complete response (CR) in 40% of newly diagnosed older patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, many of whom had adverse prognostic features </plain></SENT>
<SENT sid="4" pm="."><plain>The median overall survival (OS) was 318 days but there was prolonged survival in responders of 481 days </plain></SENT>
<SENT sid="5" pm="."><plain>Relapsed/refractory patients had a CR rate of 15.7% with a median OS of 177 days </plain></SENT>
<SENT sid="6" pm="."><plain>Extramedullary toxicity was mild and the regimen was well tolerated for ongoing post-remission, outpatient maintenance cycles </plain></SENT>
<SENT sid="7" pm="."><plain>Responses were durable for over 1 year </plain></SENT>
</text></document>